Advanced Cell Technology Announces Investor Conference Call To Be Held Friday January 19 To Discuss Key Events And Progress In Stem Cell-Based Therapeutic Programs

ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, will host an investor conference call on Friday, January 19, at 12 noon Eastern, to discuss recent progress and events with respect to the Company’s initiatives to develop stem cell-based therapies for a range of diseases and conditions.